Amlodipine And Valsartan Tablet, Film Coated
Product Images NDC 46708-461

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Amlodipine And Valsartan (NDC 46708-461). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Alembic Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30's Bottle Label (Amlovalsartan 10 160mg)

Amlodipine and Valsartan Tablets, USP 10 mg/160 mg film-coated, oral tablets label contains 30 tablets per package. The label displays the NDC 46708-459-30 and states the product is manufactured by Alembic Pharmaceuticals Limited in Gujarat, India. It includes dosage and storage instructions, barcode, and lot/expiry placeholders.*

FDA Label Image

30's Bottle Pack (Amlovalsartan 10 320)

Label for Amlodipine and Valsartan Tablets USP 10 mg/320 mg, film-coated oral tablets. The label shows a package of 30 tablets, manufactured by Alembic Pharmaceuticals Limited, with storage instructions to keep at 25°C (77°F) with excursion allowances and to protect from moisture. It includes NDC 46708-461-30 and batch information fields.*

FDA Label Image

30's Bottle Pack (Amlovalsartan 5 160)

Label for Amlodipine and Valsartan Tablets, USP, 5 mg/160 mg strength. The package contains 30 film-coated oral tablets. It is labeled for prescription use only and manufactured by Alembic Pharmaceuticals Limited. Storage instructions and dosage information are partially visible.*

FDA Label Image

30's Bottle Label (Amlovalsartan 5 320mg)

Packaging label for Amlodipine and Valsartan Tablets USP 5 mg/320 mg by Alembic Pharmaceuticals Limited. The label shows a tablet count of 30, with NDC 46708-460-30, and instructions to store at 25°C (77°F) with permitted excursions. It includes manufacturer details and a barcode.*

FDA Label Image

Amlodipine Besylate (Amlovalsartan Str1)

Chemical structure of Amlodipine and Valsartan active ingredients. The image shows molecular diagrams representing the compounds including a chlorinated aromatic ring, ester groups, and a sulfonic acid functional group.*

FDA Label Image

Valsartan (Amlovalsartan Str2)

Chemical structure of the active ingredient Amlodipine and Valsartan, showing the molecular arrangement and bonds between atoms.*

FDA Label Image

Figure 1 (Amlovalsartanl Figure1)

This plot illustrates the probability of achieving systolic blood pressure (SBP) under 140 mmHg based on baseline SBP (mmHg) for four different treatments: Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo. The y-axis represents the percentage of patients achieving target SBP, while the x-axis shows baseline SBP values ranging from 140 to 180 mmHg.*

FDA Label Image

Figure 2 (Amlovalsartanl Figure2)

A line graph titled 'Probability of Achieving Diastolic Blood Pressure <90 mmHg at Week 8' comparing the effectiveness of different treatments: Amlodipine and Valsartan Tablets USP 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and Placebo. The x-axis represents Baseline Diastolic Blood Pressure (DBP) in mmHg (ranges from 95 to 110), and the y-axis shows the percentage of patients achieving DBP <90 mmHg. The combination tablet has the highest probability, followed by Valsartan, Amlodipine, and then placebo.*

FDA Label Image

Figure 3 (Amlovalsartanl Figure3)

A line graph showing the probability of achieving systolic blood pressure under 130 mmHg at week 8. The y-axis represents the percentage of diastolic blood pressure below 90 mmHg, and the x-axis represents baseline systolic blood pressure in mmHg. The graph compares four groups: Amlodipine and Valsartan 10/320 mg tablets, Valsartan 320 mg, Amlodipine 10 mg, and placebo, with Amlodipine and Valsartan showing the highest probability of achieving the target blood pressure.*

FDA Label Image

Figure 4 (Amlovalsartanl Figure4)

A scatter plot chart showing the probability of achieving diastolic blood pressure less than 80 mmHg at week 8 based on baseline DBP values (mmHg). The data compares Amlodipine and Valsartan tablets 10/320 mg, Valsartan 320 mg, Amlodipine 10 mg, and placebo groups with distinct marker symbols and a legend. The y-axis is labeled as % DBP <80 mmHg, ranging from 0 to 100%, and the x-axis shows baseline DBP from 95 to 110 mmHg.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.